These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1100971)

  • 1. A report on a controlled clinical trial with conventional and one third conventional dose of dapsone administered orally once a week in lepromatous patients.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):93-7. PubMed ID: 1100971
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy.
    Yawalkar SJ; McDougall AC; Languillon J; Ghosh S; Hajra SK; Opromolla DV; Tonello CJ
    Lancet; 1982 May; 1(8283):1199-202. PubMed ID: 6122970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 7. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin followed by 1 year of daily dapsone with 10 weekly doses of rifampicin.
    Pattyn SR; Groenen G; Bourland J; Grillone S; Janssens L
    Lepr Rev; 1987 Dec; 58(4):349-58. PubMed ID: 3323751
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal reaction to dapsone during treatment of leprosy.
    Frey HM; Gershon AA; Borkowsky W; Bullock WE
    Ann Intern Med; 1981 Jun; 94(6):777-9. PubMed ID: 7235421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicentre controlled comparative trial of clofazimine and dapsone in low dosages.
    Ahrens TF; Pettit JH; Ridley DS; Glaus L
    Lepr Rev; 1975 Dec; 46(4):287-96. PubMed ID: 1107728
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 16. Trial of high dosages of dapsone in the treatment of tuberculoid leprosy.
    Prasad BN
    Lepr Rev; 1971 Jun; 42(2):118-20. PubMed ID: 5150030
    [No Abstract]   [Full Text] [Related]  

  • 17. Borderline leprosy reactions and dapsone.
    Lancet; 1977 Jan; 1(8001):44-5. PubMed ID: 63682
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactive episodes in borderline lepromatous leprosy--a case report.
    Acharya PV; Gupta OP; Nigam SP; Agrawal RV
    Lepr India; 1976 Jul; 48(3):311-3. PubMed ID: 1022972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.